Murphy N P, Cordier J, Glowinski J, Prémont J
Laboratoire de Neuropharmacologie, INSERM U114, Collège de France, Paris.
Eur J Neurosci. 1994 May 1;6(5):854-60. doi: 10.1111/j.1460-9568.1994.tb00995.x.
The present study investigates the roles of protein kinase C (PKC) and A (PKA) activities in NMDA-mediated Ca2+ entry in primary cultures of mouse striatal neurons. Inhibitors of protein kinases, such as sphingosine, RO 31-8220 and staurosporine inhibited the NMDA- but also the KCl-induced rise in cytosolic Ca2+. However, the PKA antagonist Rp-adenosine-3',5'monophosphothioate (Rp-cAMPS) did not alter the NMDA+D-serine response, whereas it completely suppressed the KCl response. The NMDA+D-serine-evoked rise in cytosolic Ca2+, observed in the absence of external Mg2+, was potentiated by the PKC activator phorbol 12-myristate 13-acetate (PMA) only when submaximal effective concentrations of this agonist and co-agonist were used. In addition, the PKC activator did not alter the NMDA+D-serine-evoked response in the presence of varying concentrations of Mg2+. Confirming the dependence on PKC activity, desensitization of PKC resulting from long-term PMA treatment led to an impairment of the NMDA response, leaving the KCl-induced response intact. We therefore propose that PKC not only potentiates but is also required for the NMDA-evoked elevation in cytosolic Ca2+ in mouse striatal neurons.
本研究调查了蛋白激酶C(PKC)和蛋白激酶A(PKA)活性在小鼠纹状体神经元原代培养物中N-甲基-D-天冬氨酸(NMDA)介导的Ca2+内流中的作用。蛋白激酶抑制剂,如鞘氨醇、RO 31-8220和星形孢菌素,不仅抑制NMDA诱导的,也抑制氯化钾(KCl)诱导的胞质Ca2+升高。然而,PKA拮抗剂Rp-腺苷-3',5'-单磷酸硫代酸酯(Rp-cAMPS)并未改变NMDA+D-丝氨酸反应,而它完全抑制了KCl反应。在无细胞外Mg2+的情况下观察到的NMDA+D-丝氨酸诱发的胞质Ca2+升高,仅当使用该激动剂和共激动剂的亚最大有效浓度时,才被PKC激活剂佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)增强。此外,PKC激活剂在存在不同浓度Mg2+的情况下并未改变NMDA+D-丝氨酸诱发的反应。长期PMA处理导致PKC脱敏,从而证实了对PKC活性的依赖性,这导致NMDA反应受损,而KCl诱导的反应保持完整。因此,我们提出PKC不仅增强小鼠纹状体神经元中NMDA诱发的胞质Ca2+升高,而且是其必需条件。